Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Goodwill & Intangibles (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Goodwill & Intangibles for 16 consecutive years, with $705000.0 as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles fell 16.17% to $705000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $705000.0 through Dec 2025, down 16.17% year-over-year, with the annual reading at $705000.0 for FY2025, 16.17% down from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $705000.0 at Plus Therapeutics, down from $746000.0 in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $929000.0 in Q2 2024, with the low at $405000.0 in Q1 2024.
  • Average Goodwill & Intangibles over 5 years is $584789.5, with a median of $485000.0 recorded in 2022.
  • The sharpest move saw Goodwill & Intangibles surged 113.07% in 2024, then dropped 16.79% in 2025.
  • Over 5 years, Goodwill & Intangibles stood at $432000.0 in 2021, then increased by 7.87% to $466000.0 in 2022, then fell by 11.16% to $414000.0 in 2023, then soared by 103.14% to $841000.0 in 2024, then decreased by 16.17% to $705000.0 in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods came in at $705000.0, $746000.0, and $773000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.